102 related articles for article (PubMed ID: 24733153)
1. Determination of the influence of home delivery of HIV therapy on virological outcomes and adherence.
Castelino S; Miah H; Auyeung V; Vogt F
Int J STD AIDS; 2015 Feb; 26(2):93-7. PubMed ID: 24733153
[TBL] [Abstract][Full Text] [Related]
2. Improving adherence and clinical outcomes through an HIV pharmacist's interventions.
Ma A; Chen DM; Chau FM; Saberi P
AIDS Care; 2010 Oct; 22(10):1189-94. PubMed ID: 20640958
[TBL] [Abstract][Full Text] [Related]
3. Association between pharmacy medication refill-based adherence rates and cd4 count and viral-load responses: A retrospective analysis in treatment-experienced adults with HIV.
Townsend ML; Jackson GL; Smith R; Wilson KH
Clin Ther; 2007 Apr; 29(4):711-6. PubMed ID: 17617294
[TBL] [Abstract][Full Text] [Related]
4. Evaluating adherence to medication in children and adolescents with HIV.
Khan M; Song X; Williams K; Bright K; Sill A; Rakhmanina N
Arch Dis Child; 2009 Dec; 94(12):970-3. PubMed ID: 19723637
[TBL] [Abstract][Full Text] [Related]
5. The Effect of an Integrated Health System Specialty Pharmacy on HIV Antiretroviral Therapy Adherence, Viral Suppression, and CD4 Count in an Outpatient Infectious Disease Clinic.
Barnes E; Zhao J; Giumenta A; Johnson M
J Manag Care Spec Pharm; 2020 Feb; 26(2):95-102. PubMed ID: 32011966
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of a home-delivery service for HIV-infected patients attending an inner London HIV treatment centre.
Harte D; Hamill M; Edwards SG; Copas AJ; Minton J; Jones VL; Allason-Jones E; Williams IG; Miller RF
Int J STD AIDS; 2008 Aug; 19(8):533-5. PubMed ID: 18663039
[TBL] [Abstract][Full Text] [Related]
7. A time-to-prescription-refill measure of antiretroviral adherence predicted changes in viral load in HIV.
Grossberg R; Zhang Y; Gross R
J Clin Epidemiol; 2004 Oct; 57(10):1107-10. PubMed ID: 15528063
[TBL] [Abstract][Full Text] [Related]
8. Improved virological suppression in children on antiretroviral treatment receiving community-based adherence support: a multicentre cohort study from South Africa.
Fatti G; Shaikh N; Eley B; Grimwood A
AIDS Care; 2014 Apr; 26(4):448-53. PubMed ID: 24215157
[TBL] [Abstract][Full Text] [Related]
9. Linkage and retention in care and the time to HIV viral suppression and viral rebound - New York City.
Robertson M; Laraque F; Mavronicolas H; Braunstein S; Torian L
AIDS Care; 2015; 27(2):260-7. PubMed ID: 25244545
[TBL] [Abstract][Full Text] [Related]
10. Outpatient pharmacy care and HIV viral load response among patients on HAART.
Castillo E; Palepu A; Beardsell A; Akagi L; Yip B; Montaner JS; Hogg RS
AIDS Care; 2004 May; 16(4):446-57. PubMed ID: 15203413
[TBL] [Abstract][Full Text] [Related]
11. Number of daily pills, dosing schedule, self-reported adherence and health status in 2010: a large cross-sectional study of HIV-infected patients on antiretroviral therapy.
Gianotti N; Galli L; Bocchiola B; Cahua T; Panzini P; Zandonà D; Salpietro S; Maillard M; Danise A; Pazzi A; Lazzarin A; Castagna A
HIV Med; 2013 Mar; 14(3):153-60. PubMed ID: 22994659
[TBL] [Abstract][Full Text] [Related]
12. Outcomes of a remote, decentralized health center-based HIV/AIDS antiretroviral program in Zambia, 2003 to 2007.
Elema R; Mills C; Yun O; Lokuge K; Ssonko C; Nyirongo N; Mtonga V; Zulu H; Tu D; Verputten M; O'Brien DP
J Int Assoc Physicians AIDS Care (Chic); 2009; 8(1):60-7. PubMed ID: 19211930
[TBL] [Abstract][Full Text] [Related]
13. Time to viral load suppression in antiretroviral-naive and -experienced HIV-infected pregnant women on highly active antiretroviral therapy: implications for pregnant women presenting late in gestation.
Aziz N; Sokoloff A; Kornak J; Leva NV; Mendiola ML; Levison J; Feakins C; Shannon M; Cohan D
BJOG; 2013 Nov; 120(12):1534-47. PubMed ID: 23924192
[TBL] [Abstract][Full Text] [Related]
14. Factors before enrolment are associated with being removed from a Pharmacy-only Refill Programme at a large urban HIV/AIDS clinic, Uganda.
Nakiwogga-Muwanga A; Katabira E; Kiragga A; Kambugu A; Nakibuuka-Lubwama E; Manabe YC; Alamo ST; Colebunders R
Int J STD AIDS; 2014 Feb; 25(2):105-12. PubMed ID: 23970633
[TBL] [Abstract][Full Text] [Related]
15. Keeping kids in care: virological failure in a paediatric antiretroviral clinic and suggestions for improving treatment outcomes.
Purchase S; Cunningham J; Esser M; Skinner D
Afr J AIDS Res; 2016 Sep; 15(3):301-9. PubMed ID: 27681154
[TBL] [Abstract][Full Text] [Related]
16. [National consensus document by GESIDA/National Aids Plan on antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2011 update)].
Panel de expertos de GESIDA y Plan Nacional sobre el Sida
Enferm Infecc Microbiol Clin; 2011 Mar; 29(3):209.e1-103. PubMed ID: 21388714
[TBL] [Abstract][Full Text] [Related]
17. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
Van Vaerenbergh K
Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
[TBL] [Abstract][Full Text] [Related]
18. Changes in viral load in people with virological failure who remain on the same HAART regimen.
Cozzi-Lepri A; Phillips AN; Miller V; Katlama C; Ledergerber B; Vella S; Weber J; Bruun JN; Kirk O; Clotet B; Lundgrens JD
Antivir Ther; 2003 Apr; 8(2):127-36. PubMed ID: 12741625
[TBL] [Abstract][Full Text] [Related]
19. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].
Panel de expertos de Gesida y Plan Nacional sobre el Sida
Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):222-35. PubMed ID: 19246124
[TBL] [Abstract][Full Text] [Related]
20. Effect of hepatitis C infection on progression of HIV disease and early response to initial antiretroviral therapy.
Sullivan PS; Hanson DL; Teshale EH; Wotring LL; Brooks JT
AIDS; 2006 May; 20(8):1171-9. PubMed ID: 16691069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]